A carregar...
The revival of CpG oligonucleotide-based cancer immunotherapies
The promising results of clinical trials using immune checkpoint inhibitors revived interests in cancer immunotherapy. However, it also became apparent that efficacy of immune checkpoint blockade can benefit from combining it with immunostimulatory strategies. Here, we review prior and re-emerging a...
Na minha lista:
| Publicado no: | Contemp Oncol (Pozn) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885070/ https://ncbi.nlm.nih.gov/pubmed/29628795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73887 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|